FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058347788> ?p ?o ?g. }

• W2058347788 endingPage "57" @default.
• W2058347788 startingPage "53" @default.
• W2058347788 abstract "Objective. To determine whether neoadjuvant cisplatin and 5-fluorouracil chemotherapy can be used to preserve the anal sphincter and/or urethra in patients with advanced vulvar cancer involving these sites. Methods. Fourteen patients with advanced vulvar cancer (1997–2003) involving the anal sphincter and/or urethra were given 3–4 cycles of neoadjuvant chemotherapy to attempt preservation of these pelvic structures rather than undergoing a primary pelvic exenteration. Following 3 cycles, a radical vulvectomy and groin lymph node dissection were planned. All patients had lesion size documented by measurement and photograph prior to and following chemotherapy. Results. The median age was 63 years (range 39–88). Thirteen patients received a median of 3 cycles (range 2–4) of neoadjuvant chemotherapy. Ten patients received cisplatin and 5-fluorouracil, while three received cisplatin alone. The median time from diagnosis to surgery was 77 days (range 54–143). All patients with cisplatin and 5-fluorouracil chemotherapy underwent surgery except one patient who had a synchronous renal cell carcinoma and died prior to surgery. Patients receiving cisplatin alone showed no measurable response, while all patients receiving cisplatin and 5-fluorouracil demonstrated at least a partial response. Two patients had no residual invasive carcinoma on final pathology. All patients receiving cisplatin and 5-fluorouracil followed by surgery are disease-free, while two of three receiving cisplatin have progressive disease. The anal sphincter and urethra were conserved in all patients receiving cisplatin and 5-fluorouracil. Conclusion. Neoadjuvant cisplatin and 5-fluorouracil in advanced vulvar cancer demonstrated a response rate of 100%. The anal sphincter and urethra were conserved in all patients receiving cisplatin and 5-fluorouracil. Responders are disease-free at this time. This response rate demonstrates superior activity of 5-fluorouracil in vulvar cancer and spares these patients the morbidity of exenteration or radiation." @default.
• W2058347788 created "2016-06-24" @default.
• W2058347788 creator A5051787168 @default.
• W2058347788 creator A5052301189 @default.
• W2058347788 creator A5062865263 @default.
• W2058347788 date "2006-01-01" @default.
• W2058347788 modified "2023-09-25" @default.
• W2058347788 title "Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary exenteration" @default.
• W2058347788 cites W1979445325 @default.
• W2058347788 cites W1984066460 @default.
• W2058347788 cites W1991449390 @default.
• W2058347788 cites W1993577287 @default.
• W2058347788 cites W2009096565 @default.
• W2058347788 cites W2010000977 @default.
• W2058347788 cites W2012385586 @default.
• W2058347788 cites W2027677325 @default.
• W2058347788 cites W2037951950 @default.
• W2058347788 cites W2047370015 @default.
• W2058347788 cites W2048093982 @default.
• W2058347788 cites W2051615566 @default.
• W2058347788 cites W2057621991 @default.
• W2058347788 cites W2063787608 @default.
• W2058347788 cites W2093426923 @default.
• W2058347788 cites W2109694492 @default.
• W2058347788 doi "https://doi.org/10.1016/j.ygyno.2005.06.068" @default.
• W2058347788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16257042" @default.
• W2058347788 hasPublicationYear "2006" @default.
• W2058347788 type Work @default.
• W2058347788 sameAs 2058347788 @default.
• W2058347788 citedByCount "72" @default.
• W2058347788 countsByYear W20583477882012 @default.
• W2058347788 countsByYear W20583477882013 @default.
• W2058347788 countsByYear W20583477882014 @default.
• W2058347788 countsByYear W20583477882015 @default.
• W2058347788 countsByYear W20583477882016 @default.
• W2058347788 countsByYear W20583477882017 @default.
• W2058347788 countsByYear W20583477882018 @default.
• W2058347788 countsByYear W20583477882019 @default.
• W2058347788 countsByYear W20583477882020 @default.
• W2058347788 countsByYear W20583477882021 @default.
• W2058347788 countsByYear W20583477882022 @default.
• W2058347788 countsByYear W20583477882023 @default.
• W2058347788 crossrefType "journal-article" @default.
• W2058347788 hasAuthorship W2058347788A5051787168 @default.
• W2058347788 hasAuthorship W2058347788A5052301189 @default.
• W2058347788 hasAuthorship W2058347788A5062865263 @default.
• W2058347788 hasConcept C126894567 @default.
• W2058347788 hasConcept C141071460 @default.
• W2058347788 hasConcept C2776316342 @default.
• W2058347788 hasConcept C2776694085 @default.
• W2058347788 hasConcept C2778239845 @default.
• W2058347788 hasConcept C2780370617 @default.
• W2058347788 hasConcept C2780456651 @default.
• W2058347788 hasConcept C2780504313 @default.
• W2058347788 hasConcept C2781027925 @default.
• W2058347788 hasConcept C2909580181 @default.
• W2058347788 hasConcept C71924100 @default.
• W2058347788 hasConceptScore W2058347788C126894567 @default.
• W2058347788 hasConceptScore W2058347788C141071460 @default.
• W2058347788 hasConceptScore W2058347788C2776316342 @default.
• W2058347788 hasConceptScore W2058347788C2776694085 @default.
• W2058347788 hasConceptScore W2058347788C2778239845 @default.
• W2058347788 hasConceptScore W2058347788C2780370617 @default.
• W2058347788 hasConceptScore W2058347788C2780456651 @default.
• W2058347788 hasConceptScore W2058347788C2780504313 @default.
• W2058347788 hasConceptScore W2058347788C2781027925 @default.
• W2058347788 hasConceptScore W2058347788C2909580181 @default.
• W2058347788 hasConceptScore W2058347788C71924100 @default.
• W2058347788 hasIssue "1" @default.
• W2058347788 hasLocation W20583477881 @default.
• W2058347788 hasLocation W20583477882 @default.
• W2058347788 hasOpenAccess W2058347788 @default.
• W2058347788 hasPrimaryLocation W20583477881 @default.
• W2058347788 hasRelatedWork W13394025 @default.
• W2058347788 hasRelatedWork W1979540020 @default.
• W2058347788 hasRelatedWork W2012984247 @default.
• W2058347788 hasRelatedWork W2058347788 @default.
• W2058347788 hasRelatedWork W2363409655 @default.
• W2058347788 hasRelatedWork W2394853503 @default.
• W2058347788 hasRelatedWork W2406263212 @default.
• W2058347788 hasRelatedWork W2409439767 @default.
• W2058347788 hasRelatedWork W2473408037 @default.
• W2058347788 hasRelatedWork W3100012893 @default.
• W2058347788 hasVolume "100" @default.
• W2058347788 isParatext "false" @default.
• W2058347788 isRetracted "false" @default.
• W2058347788 magId "2058347788" @default.
• W2058347788 workType "article" @default.